Radical prostatectomy vs radiotherapy in high-risk prostate cancer patients: two centre experience
Background/objective There are no randomized trials on the comparative effectiveness of radical prostatectomy (RP) and radiotherapy (RT) for high-risk prostate cancer. Our aim was to compare treatment outcomes of high-risk prostate cancer after RP and RT, including overall survival (OS), biochemical...
Main Authors: | , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Vilnius University Press
2015-01-01
|
Series: | Lietuvos Chirurgija |
Subjects: | |
Online Access: | http://www.journals.vu.lt/lietuvos-chirurgija/article/view/5106 |
_version_ | 1823991295613337600 |
---|---|
author | Albertas Ulys Agne Ulyte Pavel Dziameshka Oleg Sukonko Sergei Krasny Sergei Polyakov Giedre Smailyte |
author_facet | Albertas Ulys Agne Ulyte Pavel Dziameshka Oleg Sukonko Sergei Krasny Sergei Polyakov Giedre Smailyte |
author_sort | Albertas Ulys |
collection | DOAJ |
description | Background/objective
There are no randomized trials on the comparative effectiveness of radical prostatectomy (RP) and radiotherapy (RT) for high-risk prostate cancer. Our aim was to compare treatment outcomes of high-risk prostate cancer after RP and RT, including overall survival (OS), biochemical-progression-free survival (bPFS) and disease-progression-free survival (dPFS), using two cancer treatments centers’ patient data.
Methods
Data on high-risk prostate cancer patients between 2005 and 2009 were retrospectively reviewed in two cancer centers: National Cancer Institute, Vilnius, Lithuania and N.N. Alexandrov National Cancer Centre of Belarus, Minsk, Belarus; 210 patients were included in the study group treated with RP (n = 174) or RT (n = 36). The mean follow-up time was 5.6 and 6.6 years, respectively.
Results
Lower T stage was an independent predictor of better OS (p = 0.01) and bPFS (p = 0.03). Only the highest Gleason score ≥8 was significantly predictive of a worse OS (p = 0.05), bPFS (p = 0.02) and dPFS (p = 0.001). A high PSA level was predictive of a worse bPFS (p = 0.007 for PSA ≥20) and dPFS (p = 0.008 for ≥20). The treatment modality in this study was insignificant after T stage, Gleason score and PSA level adjustment for OS, bPFS survival and dPFS survival (p = 0.17, p = 0.39, p = 0.20).
Conclusions
The T stage, Gleason score and pretreatment PSA level are significant factors for OS, bPFS survival, and dPFS survival of highrisk prostate cancer patients. Treatment option (RP or RT) was not an independent predictor of survival in this study. |
first_indexed | 2024-12-18T15:52:04Z |
format | Article |
id | doaj.art-a092ea949c2a4bb291e9248b2e8bc0e8 |
institution | Directory Open Access Journal |
issn | 1392-0995 1648-9942 |
language | English |
last_indexed | 2024-12-18T15:52:04Z |
publishDate | 2015-01-01 |
publisher | Vilnius University Press |
record_format | Article |
series | Lietuvos Chirurgija |
spelling | doaj.art-a092ea949c2a4bb291e9248b2e8bc0e82022-12-21T21:02:33ZengVilnius University PressLietuvos Chirurgija1392-09951648-99422015-01-01134Radical prostatectomy vs radiotherapy in high-risk prostate cancer patients: two centre experienceAlbertas UlysAgne UlytePavel DziameshkaOleg SukonkoSergei KrasnySergei PolyakovGiedre SmailyteBackground/objective There are no randomized trials on the comparative effectiveness of radical prostatectomy (RP) and radiotherapy (RT) for high-risk prostate cancer. Our aim was to compare treatment outcomes of high-risk prostate cancer after RP and RT, including overall survival (OS), biochemical-progression-free survival (bPFS) and disease-progression-free survival (dPFS), using two cancer treatments centers’ patient data. Methods Data on high-risk prostate cancer patients between 2005 and 2009 were retrospectively reviewed in two cancer centers: National Cancer Institute, Vilnius, Lithuania and N.N. Alexandrov National Cancer Centre of Belarus, Minsk, Belarus; 210 patients were included in the study group treated with RP (n = 174) or RT (n = 36). The mean follow-up time was 5.6 and 6.6 years, respectively. Results Lower T stage was an independent predictor of better OS (p = 0.01) and bPFS (p = 0.03). Only the highest Gleason score ≥8 was significantly predictive of a worse OS (p = 0.05), bPFS (p = 0.02) and dPFS (p = 0.001). A high PSA level was predictive of a worse bPFS (p = 0.007 for PSA ≥20) and dPFS (p = 0.008 for ≥20). The treatment modality in this study was insignificant after T stage, Gleason score and PSA level adjustment for OS, bPFS survival and dPFS survival (p = 0.17, p = 0.39, p = 0.20). Conclusions The T stage, Gleason score and pretreatment PSA level are significant factors for OS, bPFS survival, and dPFS survival of highrisk prostate cancer patients. Treatment option (RP or RT) was not an independent predictor of survival in this study.http://www.journals.vu.lt/lietuvos-chirurgija/article/view/5106high-risk prostate cancerradical prostatectomyradiotherapy |
spellingShingle | Albertas Ulys Agne Ulyte Pavel Dziameshka Oleg Sukonko Sergei Krasny Sergei Polyakov Giedre Smailyte Radical prostatectomy vs radiotherapy in high-risk prostate cancer patients: two centre experience Lietuvos Chirurgija high-risk prostate cancer radical prostatectomy radiotherapy |
title | Radical prostatectomy vs radiotherapy in high-risk prostate cancer patients: two centre experience |
title_full | Radical prostatectomy vs radiotherapy in high-risk prostate cancer patients: two centre experience |
title_fullStr | Radical prostatectomy vs radiotherapy in high-risk prostate cancer patients: two centre experience |
title_full_unstemmed | Radical prostatectomy vs radiotherapy in high-risk prostate cancer patients: two centre experience |
title_short | Radical prostatectomy vs radiotherapy in high-risk prostate cancer patients: two centre experience |
title_sort | radical prostatectomy vs radiotherapy in high risk prostate cancer patients two centre experience |
topic | high-risk prostate cancer radical prostatectomy radiotherapy |
url | http://www.journals.vu.lt/lietuvos-chirurgija/article/view/5106 |
work_keys_str_mv | AT albertasulys radicalprostatectomyvsradiotherapyinhighriskprostatecancerpatientstwocentreexperience AT agneulyte radicalprostatectomyvsradiotherapyinhighriskprostatecancerpatientstwocentreexperience AT paveldziameshka radicalprostatectomyvsradiotherapyinhighriskprostatecancerpatientstwocentreexperience AT olegsukonko radicalprostatectomyvsradiotherapyinhighriskprostatecancerpatientstwocentreexperience AT sergeikrasny radicalprostatectomyvsradiotherapyinhighriskprostatecancerpatientstwocentreexperience AT sergeipolyakov radicalprostatectomyvsradiotherapyinhighriskprostatecancerpatientstwocentreexperience AT giedresmailyte radicalprostatectomyvsradiotherapyinhighriskprostatecancerpatientstwocentreexperience |